Sage Journals: Discover world-class research

Retricted access

Research article

First published 2006-06

Persistence of neutralizing antibodies after discontinuation of IFNβ therapy in patients with relapsing-remitting multiple sclerosis

Bodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-09

The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis

Maria Trojano, Pierluigi Russo, Aurora Fuiani [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-11

Qualitative and quantitative analysis of antibody response against IFNβ in patients with multiple sclerosis

F Gilli, F Hoffmann, A Sala [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2022-06

Asn25 Deamidation as an Allosteric Tool to Increase IFNβ-1a Biological Activity

Elisa Lipari, Simona Saporiti, Ivano Eberini [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2012-5

EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy

Manuel Comabella, Kristina Kakalacheva, Jordi Río [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-11

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients

C Gneiss, P Tripp, F Reichartseder [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2003-08

Necrotizing skin lesions and NA Bs development in a multiple sclerosis patient treated with IFNβ 1b

Federica Casoni, Elisa Merelli, Roberta Bedin [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2001-12

A prospective,open-label treatment trial to compare the effect of IFNβ-1a (Avonex®),IFNβ-1b (Betaseron®),and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

Omar A Khan, Alexandros C Tselis, John A Kamholz [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-8

Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis

R Zivadinov, MG Dwyer, S Hussein [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-09

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS

Lianwen Zhang, Michael B. Steele, Nathan Jenks [...]

Human Gene Therapy Clinical Development

Search results